Work Programme on Just Transition Pathways: Workshop Discusses Way Forward at COP28

1 December 2023 UN Climate Change News, 1 December 2023 – Earlier this week, more than 130 Parties and observers took part in a workshop to discuss the way forward on the work programme on just transition pathways at COP28. The work programme on just transition pathways, which was established at COP27 last year, is meant to assess, design and scale up pathways to achieve the goals of … Continue reading Work Programme on Just Transition Pathways: Workshop Discusses Way Forward at COP28

Impact Newswire03/12/202328/05/2024

Global, United States

NatureWorks Appoints Erik Ripple as New President and CEO

Ripple joins NatureWorks as it continues market-leading growth and innovation with construction of new 75kta Ingeo biopolymer manufacturing facility underway in Thailand November 28, 2023 09:15 AM Eastern Standard Time PLYMOUTH, Minn.–(BUSINESS WIRE)–Today NatureWorks, a leading manufacturer of polylactic acid (PLA) biopolymers made from renewable resources, announced the appointment of Erik Ripple as the company’s new President and Chief Executive Officer. Ripple will succeed interim President … Continue reading NatureWorks Appoints Erik Ripple as New President and CEO

Impact Newswire02/12/202302/12/2023

Global, United States

Cadex Solutions Acquires DAL, Inc.

November 28, 2023 09:05 AM Eastern Standard Time MIAMI–(BUSINESS WIRE)–Trivest Partners (“Trivest”) is pleased to announce its portfolio company Cadex Solutions (“Cadex”) has acquired DAL, Inc. (“DAL”). Founded in 1974, DAL has developed a sterling reputation within the industry for delivering personalized services and enhanced management of commercial receivables for its clients. The DAL acquisition expands the executive leadership and industry coverage of Cadex Solutions … Continue reading Cadex Solutions Acquires DAL, Inc.

Impact Newswire02/12/202302/12/2023

Global, United States

Aro Biotherapeutics Secures $41.5M Series B Financing

– Funds will support progression of Aro’s pipeline of Centyrin-siRNA programs, including ABX1100, a novel potential treatment for Pompe Disease. – Christopher Picariello, President, Johnson & Johnson Innovation – JJDC, Inc. named to Board of Directors. November 28, 2023 09:00 AM Eastern Standard Time PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced it has secured $41.5M in a … Continue reading Aro Biotherapeutics Secures $41.5M Series B Financing

Impact Newswire02/12/202302/12/2023

Global, United States

Adams Street Partners Names Michael Kurlander as Partner and Chief Financial Officer

November 28, 2023 09:00 AM Eastern Standard Time CHICAGO–(BUSINESS WIRE)–Adams Street Partners, LLC, a private markets investment firm with more than $58 billion in assets under management (“Adams Street”), today announced that Michael Kurlander has been named Partner and Chief Financial Officer. Effective January 3, 2024, Kurlander will sit on the firm’s Executive Committee and report toJeff Diehl, Managing Partner and Head of Investments. “Michael’s … Continue reading Adams Street Partners Names Michael Kurlander as Partner and Chief Financial Officer

Impact Newswire02/12/202302/12/2023